- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Lumisys turns profit despite dip in revenues
Lumisys turns profit despite dip in revenuesRevenues at Lumisys declined 24% during the company's second quarter. For the period (end-June), revenues were $5.4 million, compared with $7.2 million last year. The firm did post a profit of $62,000,
Lumisys turns profit despite dip in revenues
Revenues at Lumisys declined 24% during the company's second quarter. For the period (end-June), revenues were $5.4 million, compared with $7.2 million last year. The firm did post a profit of $62,000, however, compared with a net loss of $141,000 in 1997. Company executives believe the financial performance will improve going forward.
In other news, Lumisys has completed a beta test for its ACR-2000 CR system (PNN 6/98)
- Search again
- Homepage
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
